{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:58:56Z","timestamp":1790233136624,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects, China","doi-asserted-by":"publisher","award":["201504010032"],"award-info":[{"award-number":["201504010032"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Guangdong Province, China","award":["2016A030313572"],"award-info":[{"award-number":["2016A030313572"]}]},{"name":"National Project for Significant New Drugs Development, China","award":["2015ZX09J15105-002-005"],"award-info":[{"award-number":["2015ZX09J15105-002-005"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.vaccine.2018.02.050","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T15:26:02Z","timestamp":1521386762000},"page":"2199-2206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55"],"prefix":"10.1016","volume":"36","author":[{"given":"Tiantian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.050_b0005","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3181\/00379727-84-20714","article-title":"Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture","volume":"84","author":"Rowe","year":"1953","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2018.02.050_b0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.virusres.2010.01.011","article-title":"Genomic characterization of human adenovirus 36, a putative obesity agent","volume":"149","author":"Arnold","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.02.050_b0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11908-010-0084-5","article-title":"The role of adenovirus in respiratory tract infections","volume":"12","author":"Kunz","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.vaccine.2018.02.050_b0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/525261","article-title":"Severe pneumonia due to adenovirus serotype 14: a new respiratory threat?","volume":"46","author":"Louie","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.050_b0025","doi-asserted-by":"crossref","first-page":"e96674","DOI":"10.1371\/journal.pone.0096674","article-title":"Epidemiology of acute respiratory infections in children in Guangzhou: a three-year study","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.02.050_b0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2334-13-28","article-title":"Epidemiology and clinical presentation of the four human parainfluenza virus types","volume":"13","author":"Liu","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.050_b0035","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3201\/eid1811.120629","article-title":"Community outbreak of adenovirus, Taiwan, 2011","volume":"18","author":"Tsou","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.050_b0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/rmv.589","article-title":"Clinical features and treatment of adenovirus infections","volume":"18","author":"Lenaerts","year":"2008","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3201\/eid1105.041211","article-title":"Adenovirus type 7 peptide diversity during outbreak, Korea, 1995\u20132000","volume":"11","author":"Choi","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.050_b0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1086\/519938","article-title":"Outbreak of human adenovirus type 3 infection in a pediatric long-term care facility\u2013Illinois, 2005","volume":"45","author":"James","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.050_b0055","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/00006454-200010000-00011","article-title":"Adenovirus 7a: a community-acquired outbreak in a children's hospital","volume":"19","author":"Mitchell","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.02.050_b0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcv.2011.02.014","article-title":"Molecular epidemiology and clinical presentation of human adenovirus infections in Kansas City children","volume":"51","author":"Selvaraju","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1743-422X-8-23","article-title":"Adenovirus serotype 7 associated with a severe lower respiratory tract disease outbreak in infants in Shaanxi Province, China","volume":"8","author":"Tang","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2018.02.050_b0070","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1099\/vir.0.81515-0","article-title":"Comparative genomic analysis of two strains of human adenovirus type 3 isolated from children with acute respiratory infection in southern China","volume":"87","author":"Zhang","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0075","doi-asserted-by":"crossref","first-page":"e53614","DOI":"10.1371\/journal.pone.0053614","article-title":"Adenovirus serotype 3 and 7 infection with acute respiratory failure in children in Taiwan, 2010\u20132011","volume":"8","author":"Lai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.02.050_b0080","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s10096-011-1406-8","article-title":"Detection of three human adenovirus species in adults with acute respiratory infection in China","volume":"31","author":"Guo","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.050_b0085","doi-asserted-by":"crossref","first-page":"e0121375","DOI":"10.1371\/journal.pone.0121375","article-title":"Adenoviruses associated with acute respiratory diseases reported in Beijing from 2011 to 2013","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.02.050_b0090","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JCM.01928-09","article-title":"Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP","volume":"48","author":"Kajon","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0095","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/JCM.01769-08","article-title":"Outbreak of acute respiratory disease in China caused by B2 species of adenovirus type 11","volume":"47","author":"Zhu","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0100","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1128\/JCM.00282-09","article-title":"Genomic analyses of recombinant adenovirus type 11a in China","volume":"47","author":"Yang","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jcv.2012.04.018","article-title":"Severe community-acquired pneumonia caused by adenovirus type 11 in immunocompetent adults in Beijing","volume":"54","author":"Gu","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/irv.12232","article-title":"Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China, 2009\u20132012","volume":"8","author":"Lu","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2018.02.050_b0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1378\/chest.13-1186","article-title":"Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia","volume":"145","author":"Cao","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.vaccine.2018.02.050_b0120","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s13054-014-0456-6","article-title":"Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study","volume":"18","author":"Sun","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.vaccine.2018.02.050_b0125","first-page":"615","article-title":"Identification and typing of adenovirus from acute respiratory infections in pediatric patients in Beijing from 2003 to 2012","volume":"29","author":"Deng","year":"2013","journal-title":"Chinese J Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0130","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/jmv.24565","article-title":"Identification and molecular characterization of adenovirus types (HAdV-8, HAdV-37, HAdV-4, HAdV-3) in an epidemic of keratoconjunctivitis occurred in Pune, Maharashtra, Western India","volume":"88","author":"Gopalkrishna","year":"2016","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0135","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00705-014-2308-8","article-title":"Epidemical features of HAdV-3 and HAdV-7 in pediatric pneumonia in Chongqing, China","volume":"160","author":"Wo","year":"2015","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1743-422X-10-271","article-title":"Prevalence of adenovirus in children with acute respiratory tract infection in Lanzhou, China","volume":"10","author":"Jin","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2018.02.050_b0145","doi-asserted-by":"crossref","first-page":"e103058","DOI":"10.1371\/journal.pone.0103058","article-title":"Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.02.050_b0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcv.2016.03.002","article-title":"Outbreak of adenovirus type 55 infection in Israel","volume":"78","author":"Salama","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0155","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/313999","article-title":"Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group","volume":"31","author":"Gray","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.050_b0160","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.vaccine.2012.12.029","article-title":"History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system","volume":"31","author":"Hoke","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.050_b0165","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/JCM.42.4.1686-1693.2004","article-title":"Molecular analysis of adenovirus isolates from vaccinated and unvaccinated young adults","volume":"42","author":"Blasiole","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcv.2012.03.006","article-title":"A comparison of viral fitness and virulence between emergent adenovirus 14p1 and prototype adenovirus 14p strains","volume":"54","author":"Anderson","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0175","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1128\/JVI.07076-11","article-title":"Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions","volume":"86","author":"Qiu","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0180","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.vaccine.2008.12.039","article-title":"Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.050_b0185","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/mi.2015.29","article-title":"Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection","volume":"8","author":"Jeyanathan","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2017.03.029","article-title":"A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice","volume":"143","author":"Wang","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2018.02.050_b0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000019060","article-title":"In vivo and in vitro modulation of immune stimulatory capacity of primary dendritic cells by adenovirus-mediated gene transduction","volume":"15","author":"Sonderbye","year":"1998","journal-title":"Exp Clin Immunogenet"},{"key":"10.1016\/j.vaccine.2018.02.050_b0200","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/JVI.72.3.2022-2032.1998","article-title":"In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1\/E2A, or E1\/E4 deleted","volume":"72","author":"Lusky","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0205","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1002\/eji.1830251239","article-title":"Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector","volume":"25","author":"Juillard","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/CVI.05319-11","article-title":"Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity","volume":"19","author":"Choi","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0215","doi-asserted-by":"crossref","first-page":"19940","DOI":"10.1073\/pnas.0907898106","article-title":"Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1","volume":"106","author":"Benlahrech","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.02.050_b0220","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","article-title":"Immune responses to adenovirus and adeno-associated virus in humans","volume":"6","author":"Chirmule","year":"1999","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2018.02.050_b0225","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1128\/JVI.01927-13","article-title":"Homologous recombination in E3 genes of human adenovirus species D","volume":"87","author":"Singh","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0230","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jmv.20441","article-title":"Respiratory disease caused by a species B2 adenovirus in a military camp in Turkey","volume":"77","author":"Chmielewicz","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0235","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcv.2013.09.025","article-title":"Characterizing, typing, and naming human adenovirus type 55 in the era of whole genome data","volume":"58","author":"Seto","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2018.02.050_b0240","doi-asserted-by":"crossref","first-page":"12441","DOI":"10.1128\/JVI.02225-12","article-title":"Genome sequence of human adenovirus type 55, a re-emergent acute respiratory disease pathogen in China","volume":"86","author":"Zhang","year":"2012","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:26:02Z","timestamp":1759400762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18302378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":48,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0264410X18302378"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}